Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Pfizer
Hoffmann-La Roche
Pfizer
Ethicon, Inc.
Pheon Therapeutics
Xemed LLC
Pfizer
SignalChem Lifesciences Corporation
Takeda
Ethicon, Inc.
Shasqi, Inc.
Tempus AI
AstraZeneca
Sanofi
Novartis
Galvanize Therapeutics, Inc.
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
Formycon AG
ImmunoGenesis
Faeth Therapeutics
NextCure, Inc.
Black Diamond Therapeutics, Inc.
Bristol-Myers Squibb
Novartis
Elevation Oncology
Checkpoint Therapeutics, Inc.
Blueprint Medicines Corporation
Blueprint Medicines Corporation
Mirati Therapeutics Inc.
ABM Therapeutics Corporation
Inhibrx Biosciences, Inc
NantCell, Inc.
NantCell, Inc.
Galvanize Therapeutics, Inc.
Pfizer
Turning Point Therapeutics, Inc.
Breathe BioMedical Inc
Pfizer
Olympus Corporation of the Americas
EpicentRx, Inc.
NKGen Biotech, Inc.
HKGepitherapeutics
Fusion Pharmaceuticals Inc.
Breathe BioMedical Inc
Breathe BioMedical Inc
Sumitomo Pharma America, Inc.
pharmaand GmbH
Fate Therapeutics